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Prions are proteins that can assume at least two
distinct conformational states, one of which is domi-
nant and self-perpetuating. Previously we found that
a translation regulator CPEB from Aplysia, ApCPEB,
that stabilizes activity-dependent changes in syn-
aptic efficacy can display prion-like properties in
yeast. Here we find that, when exogenously ex-
pressed in sensory neurons, ApCPEB can form an
amyloidogenic self-sustaining multimer, consistent
with it being a prion-like protein. In addition, we find
that conversion of both the exogenous and the
endogenous ApCPEB to the multimeric state is
enhanced by the neurotransmitter serotonin and
that an antibody that recognizes preferentially the
multimeric ApCPEB blocks persistence of synaptic
facilitation. These results are consistent with the
idea that ApCPEB can act as a self-sustaining
prion-like protein in the nervous system and thereby
might allow the activity-dependent change in
synaptic efficacy to persist for long periods of time.
INTRODUCTION
Activity-dependent changes in synaptic efficacy and synapse
number require the synthesis of new proteins at the synapse (Ca-
sadio et al., 1999; Frey and Morris, 1997; Kang and Schuman,
1996; Martin et al., 1997; Steward and Schuman, 2001). In the
sensory to motor neuron synapses of the gill-withdrawal reflex
in Aplysia, local protein synthesis is required for at least two
distinct functions: (1) the synthesis of one or more retrograde
signals that travel from the synapse to the cell body to activate
transcription and (2) the synthesis of a local synaptic mark thatstabilizes subsequent functional and structural changes at the
activated synapse (Casadio et al., 1999; Martin et al., 1997; Mini-
aci et al., 2008). Interestingly, the protein synthesis inhibitor
rapamycin, which blocks translation of a subset of synaptic
mRNAs related to growth, does not interfere with the retrograde
signal but only blocks the stabilizing component of the synaptic
mark (Casadio et al., 1999).
In a search for the rapamycin-sensitive stabilizing component
of the synaptic mark in Aplysia, we previously identified a novel,
neuron-specific formof the cytoplasmic polyadenylation element
binding protein (CPEB), ApCPEB (Si et al., 2003a). ApCPEB
belongs to a family of RNA-binding proteins that can act as
both a translational repressor and activator of its target mRNAs
(Barkoff et al., 2000; de Moor and Richter, 1999; Hake and
Richter, 1994; Huang et al., 2006;Minshall et al., 1999).We found
that the persistence of synaptic facilitation requires ApCPEB-
mediated synaptic protein synthesis not transiently, but continu-
ously for at least 72 hr (Miniaci et al., 2008). As the activity of
ApCPEB is altered by synaptic stimulation and should have
a limited duration, this persistence of activity raised the following
question: How can the altered activity state of ApCPEB bemain-
tained for long periods of time?
One plausible solution to the problem of how a short-lived
molecule can produce enduring changes came from our earlier
studies in yeast that revealed ApCPEB to have prion-like proper-
ties (Si et al., 2003b). Prion proteins are unique because the
same protein can assume two distinct conformational states,
one of which is dominant and self-perpetuating (Coustou et al.,
1997; Derkatch et al., 2001; Osherovich and Weissman, 2001;
Prusiner, 1998; Sondheimer and Lindquist, 2000; Wickner,
1994; Wickner et al., 1995). We previously found that in yeast,
like other prion proteins, ApCPEB could exist in two distinct
conformational states, one of which is multimeric, active, and
dominantly self-perpetuating (Si et al., 2003b). Based on the
prion-like properties of ApCPEB in yeast, we proposed that
ApCPEB can assume at least two conformational states: mono-
meric andmultimeric. In a naive synapse, ApCPEB ismonomericCell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc. 421
and either inactive or acts as a repressor. Synaptic activation
leads to the conversion of ApCPEB to a dominant, self-
sustaining, active multimeric state. This creates a self-sustaining
synaptic mark limited to the specific set of synapses that have
been activated, resulting in a sustained period of translation at
the activated synapse that allows for the maintenance of the
synaptic changes. A test of this hypothesis requires an experi-
mental analysis that addresses four questions: First, does
ApCPEB have the properties of a self-perpetuating prion-like
protein in neurons? Second, is the prion-like conversion from
a monomeric to a multimeric form modulated by synaptic stimu-
lation? Third, is ApCPEB active in the multimeric, prion-like
state? Fourth, is the prion-like state of ApCPEB required for
the maintenance of long-term facilitation?
In this paper, we find that in the sensory neurons of Aplysia
both the exogenously expressed and the endogenous Aplysia
CPEB exist in two states, one of which is multimeric. The exog-
enous multimers in the sensory neuron result from a homotypic
interaction of ApCPEB. The exogenous multimers are amyloido-
genic and self-sustaining. These features are consistent with
ApCPEB having prion-like properties in the sensory neuron. In
addition we find that the multimerization of both endogenous
and exogenous ApCPEB is enhanced by repeated pulses of
5-HT, the stimulus that induces sustained change in synaptic
strength. Finally, we find that ApCPEB is active in its multimeric
state. An antibody that preferentially recognizes the multimeric
state selectively inhibits the persistence of long-term facilitation
of sensory-motor neuron synapse. These results are consistent
with the notion that ApCPEB serves a physiological function in
its self-sustaining prion-like multimeric state.
RESULTS
Aplysia CPEB Has Both Low and Stable High Molecular
Weight States in the Sensory Neuron
Prion-like proteins have two physically distinct states in the cell,
one of which is multimeric. The conversion from the monomeric
to the multimeric state is enhanced by increases in protein
concentration. Earlier we overexpressed ApCPEB in yeast and
found that the overexpressed protein formed puncta that had
similar properties to those of yeast prions (Si et al., 2003b). To
determine whether ApCPEB behaves similarly in neurons as it
does in yeast, we overexpressed EGFP-tagged ApCPEB in the
sensory neurons of Aplysia (Figure 1A) and noticed punctate
green fluorescence (>3 pixels) in all expressing neurons
(Figure 1C). The punctate appearance was not due to the
EGFP tag because ApCPEB fused to the fluorescent protein
KiKGR (Figure S1B available online and Figure 5A) or to HA
peptide (Figures 1D and 1D0) formed similar puncta (Tsutsui
et al., 2005). Efficient puncta formation requires the N-terminal
prion-like domain. Similar to what we have observed in yeast
previously, deletion of N-terminal 252 amino acids considerably
reduced the punctate appearance of ApCPEB (number of
puncta/neurite; full-length ApCPEB; 50.37 ± 5.68, N-terminal
deletion; 5.83 ± 1.19, n = 8, p < 0.001, one-way ANOVA)
(Figure 1E, Figure S2, and Table S1) (Si et al., 2003b). Thus,
when overexpressed in sensory neurons, ApCPEB can form
punctate structures consistent with a multimeric state, and the422 Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc.punctate appearance of ApCPEB requires the prion-like domain.
However, we cannot exclude the possibility that the reduced
puncta formation in N-terminal-deleted ApCPEB in sensory
neurons was due to a reduction in the level of the protein.
As we observed the punctate ApCPEB upon overexpression
in sensory neurons, it raises the question, does endogenous
AplysiaCPEB exist in a similar multimeric state or is multimeriza-
tion an artifact of overexpression? To address this question, we
took advantage of an antibody, Ab464, that we had raised
against the aggregated recombinant N-terminal 213 amino acids
and found that it specifically stains the ApCPEBEGFP puncta in
the sensory neuron (Figures 1F and 1G). We next immunoprecip-
itated endogenous ApCPEB from central nervous system (CNS)
protein extracts (0.5 mg of protein) with Ab464 and probed the
immunoprecipitate with two other antibodies, one raised against
the soluble N-terminal 213 amino acids (Ab463) and the other
against a 17 amino acids peptide (Ab77) from the C-terminal
end of the protein (Figure 1H). With both antibodies we detected
only a high molecular weight ApCPEB (>181 kDa) in the Ab464
immunoprecipitate but not in control IgG immunoprecipitate
(Figure 1H). The high molecular weight form of ApCPEB is
most likely not due to association with other proteins or mRNA
because it is stable after boiling 5 min in 10% SDS, which should
dissociate most interacting molecules. Moreover, western anal-
ysis of CNSprotein (25 mg of protein) with Ab464 failed to reveal
any monomeric ApCPEB, whereas both Ab463 and Ab77 recog-
nized the monomeric form (Figure 1I and Figure S1C).
These results are consistent with the idea that endogenous
ApCPEB can exist both as a monomer and as a stable multimer,
which migrates as a high molecular weight protein. Since the
monomeric proteinmigrates as an80 kDa protein, if it is entirely
composed of ApCPEB the high molecular weight protein should
contain at least three or more ApCPEB molecules. Our attempts
to sequence the high molecular weight protein by mass spec-
trometry have so far been unsuccessful. Therefore, we cannot
rule out the possibility that the high molecular weight protein
contains other proteins in addition to ApCPEB or that some
stable posttranslational modification of ApCPEB shifts its
mobility.
Aplysia CPEB Puncta Are Distinct from PolyQ
Aggregates
The Aplysia CPEB N-terminal domain is rich in Q residues and
polyQ rich proteins readily form aggregates in neurons. We
therefore asked, do ApCPEB form puncta simply because they
have a certain number of Q residues or does the prion-like
domain contain additional structural information that allows the
protein to form puncta in neurons? To address this question
we fused either 72Q residues or the Q/N-rich prion domain of
yeast prion Sup35 (Sup35NM) to EGFP and expressed the fusion
protein in sensory neurons (Figures 2B and 2C). We chose to
attach 72Q residues because the N-terminal 160 amino acids
of ApCPEB contain 72Q residues and 72Q residues are sufficient
to produce multimers in yeast cells (Krobitsch and Lindquist,
2000). In both caseswe observed almost no punctate green fluo-
rescence (number of puncta/neurite; 72Q, 0.5 ± 0.5, n = 7;
Sup35NM domain, 0.5 ± 0.32, n = 8) in the sensory neuron neu-
rite region, implying that puncta formation is not simply a function
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Figure 1. Both Exogenously Expressed and
Endogenous ApCPEB Form Multimers in
Neurons
(A) Schematic of the experimental design.
ApCPEB tagged with either fluorescence proteins
or HA peptide expressed from a constitutively
active promoter containing the retroviral RSV
promoter and eight binding sites for the transcrip-
tion activator AP1. The constructs were injected
into the sensory neuron cell body in the sensory
(SN)–motor (MN) neuron coculture. After 2 days
the cells were either imaged directly or stained
for HA.
(B) EGFP alone produced a diffused fluorescence.
The fluorescence puncta visible in the cell body of
the sensory neuron is autofluorescence of endog-
enous pigment granules. Because of these
pigment granules we have excluded the cell
body region from our analysis and all quantifica-
tion was done from the neurite region.
(C) ApCPEB fused to EGFP formed punctate
structures.
(D) ApCPEB tagged to HA, stained with mouse
anti-HA antibodies, and visualized with Cy3-
coupled anti-mouse IgG antibody. (D0) The same
cell in (D) is shown in a higher magnification
(scan zoom 2.4). The punctate ApCPEB staining
is clearly visible.
(E) ApCPEB lacking N-terminal 252 amino acids
produced fewer puncta. Scale bar is 20 mmexcept
in (D0) where the scale bar is 10 mm. All numbers
are mean ± standard error of the mean (SEM).
(F–I) Endogenous ApCPEB form stable multimers.
(F) ApCPEB multimers in sensory neuron were
specifically recognized by Ab464 raised against
the aggregated N-terminal domain of ApCPEB.
ApCPEBEGFP expressing sensory neurons
immunostained with affinity-purified Ab464
showed distinct punctate staining. (G) The stain-
ing was specific because it was absent in rabbit
IgG control. Scale bar, 20 mm. (H) Immunoprecip-
itation (IP) of Aplysia total CNS extract with control
rabbit IgG, Ab533, which recognizes the ApCPEB
monomer in western analysis but not in immuno-
precipitation, and the multimer-specific Ab464.
The SDS-resistant ApCPEB multimer is indicated with an asterisk (*). (I) Western blotting of total CNS extract of Aplysia with affinity-purified antibodies Ab77,
Ab463, Ab464, and Ab533. Except Ab464 all the other antibodies recognized the monomeric ApCPEB. The monomeric ApCPEB is indicated with an arrowhead.
The blots were overexposed to ensure detection of all immunoreactive polypeptides.
See also Figures S1 and S2 and Table S1.of Q/N residue number (Figures 2B and 2C and Figure S2). These
results led us to wonder whether the prion domain of ApCPEB
(ApPRD), which can form puncta in yeast albeit less efficiently,
would be able to form puncta in neurons. To our surprise we
failed to detect any puncta in sensory neurons expressing the
N-terminal domain of ApCPEB fused to EGFP (n = 6)
(Figure 2D and Figure S2).
These results have led us to the following two conclusions.
First, the N-terminal prion-like domain of ApCPEB functions
differently than simple polyQ repeats. In addition to the Q
residues, the multimerization of ApCPEB in neuron requires
additional structural components. Second, unlike in yeast, the
ApCPEB prion-like domain functions most efficiently in neurons
only in the context of the full-length protein.Puncta Formation Is a Unique Property of Aplysia CPEB
Is multimerization a unique property of neuronal CPEB variants,
or can any CPEB form multimers if overexpressed in Aplysia
sensory neurons? Mouse CPEB1 has significant sequence
homology with Aplysia CPEB except for the N-terminal prion-
like domain, which is unique for Aplysia CPEB and its homologs
in the other species. So we expressed EGFP-tagged mouse
CPEB1 (mCPEB1) in sensory neurons and observed only diffuse
fluorescence but no detectable puncta (Figure 2E and
Figure S2). To address whether the lack of multimerization is
due to lack of a prion-like domain we fused the N-terminal 252
amino acids of ApCPEB to mouse CPEB1 (ApPRDmCPEB1).
We now observed that the fusion protein formed punctate
structures in the sensory neuron (number of puncta/neurite;Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc. 423
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Figure 2. Multimerization Is a Unique Prop-
erty of ApCPEB and Distinct from PolyQ
Aggregates
The green fluorescent protein EGFP fused to full-
length Aplysia CPEB (A), to 72 glutamine residue
(72Q) (B), to yeast prion Sup35 N-terminal NM
prion domain (Sup35NM) (C), or to ApCPEB
N-terminal 252 amino acids (ApPRD) (D). All
constructs exhibited diffuse staining, except
full-length Aplysia CPEB with its characteristic
punctate appearance.
(E) Mouse CPEB1 (mCPEB1) fused to EGFP
produced diffuse fluorescence when expressed
in Aplysia sensory cell.
(F) Fusion of ApCPEB N-terminal 252 amino acids
(ApPRD) to the N-terminal end of mouse CPEB1
resulted in a punctate appearance.
(G) 72Q residues fused to the N-terminal end of
mouse CPEB1 were unable to produce punctate
structures.
(H) RNA-binding ability is not necessary for the
punctate appearance of mouse CPEB1 fused to
ApPRD.
(I) ApCPEB N-terminal 252 amino acids fused to
Aplysia RNA-binding protein Staufen does not
result in similar punctate structures.
All numbers are mean ± SEM. Scale bar, 20 mm.
See also Figure S2 and Table S1.63.75 ± 13.32, n = 8, p < 0.001, one-way ANOVA) (Figure 2F and
Figure S2).
The ability of mouse CPEB1 to form puncta in the sensory
neurons is specific to the N-terminal domain of Aplysia CPEB.
The addition of 72Q residues in front of the mouse CPEB1
(72QmCPEB1) failed to induce any puncta (number of puncta/
neurite; 0.33 ± 0.21, n = 6) (Figure 2G and Figure S2). The punc-
tate appearance was also not due to mouse CPEB1 forming
a large number of RNA-protein particles because CPEB1 was
able to form puncta when its RNA-binding domain was mutated
(ApPRDmCPEB1rbm) (number of puncta/neurite; 90.5 ± 15.95,
n = 6, p < 0.001, one-way ANOVA) (Figure 2H and Figure S2).
We next asked, can the ApCPEB prion-like domain induce
puncta formation of any RNA-binding protein or is it restricted424 Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc.to the CPEB family? To address this
question we fused the ApCPEB N-
terminal domain to the RNA-binding
protein staufen from Aplysia (Figure 2I).
Unlike CPEB1, the staufen protein
produced a few puncta and only in some
sensory neurons (number of puncta/neu-
rite; 1.33 ± 1.3, n = 6) (Figure S2). These
punctate structures are most likely
mRNA-protein particles as has been
previously reported for mammalian
staufen protein (Kohrmann et al., 1999).
These observations with staufen rein-
forced the earlier conclusion that CPEB
proteins have a latent capacity to multi-merize, and the addition of the prion-like domain accelerates
this conversion.
Aplysia CPEB Puncta Are due to Self-Assembly
of the Protein
The punctate pattern seen with ApCPEB is unlikely to be RNP
particles or P body structures involved in the degradation or
storage of mRNA for the following reasons. First, the ability to
form either RNP particles or P bodies requires RNA-binding
activity (Huang et al., 2003; Wilczynska et al., 2005). We find
that ApCPEB still formed puncta in sensory neurons even
when it lacked mRNA-binding capacity (number of puncta/neu-
rite; 140.83 ± 35.95) (Figure S3B). Second, the ApCPEB puncta
did not colocalize with P body marker Dcp1 (Figure S3C)
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Figure 3. ApCPEB Multimers Are Formed due to Self-Assembly
(A) ApCPEB multimers are due to homotypic interaction of the protein. Sche-
matic representation of the experimental design. 155 amino acids from the
N-terminal end of YFP protein (N) and 87 amino acids from the C-terminal
end of CFP protein (C) were fused to the ApCPEB protein. Self-assembly of
ApCPEB protein reconstitutes the fluorescence.
(B) CFPC and YFPN fused either to full-length ApCPEB or (C) to ApCPEB lack-
ing N-terminal 252 amino acids or (D) to ApCPEB lacking N-terminal 346 amino
acids. In all cases fluorescent punctate structures were visible indicating
homo-multimerization of the protein.
(E) ApCPEB fused to CFPC did not recruit the N-terminal end of YFP alone.
Scale bar, 20 mm. See also Figure S3.(Huang et al., 2003; Parker and Sheth, 2007; Wilczynska et al.,
2005).
To probe directly whether the punctate structures of ApCPEB
are due to prion-like, protein-protein multimerization we used a
fluorescence reconstitution assay in which a split fluorescence
protein can be reconstituted by tagging its two halves to proteins
that physically interact with one another (Hu et al., 2002; Zhang
et al., 2004). As the prion-like domain of ApCPEB is located at
the N terminus, we added the two halves of the fluorescence
protein to the C terminus of the protein assuming that multimeri-
zation might reconstitute the fluorescence (Figure 3A). When we
coexpressed ApCPEB split fluorescent constructs in sensory
neurons, we observed punctate fluorescence consistent with
the idea of ApCPEB forming homotypic multimers (Figure 3B).
We did not observe fluorescence when we coexpressed the split
fluorescent proteins with only one of them tagged to ApCPEB
(Figure 3E). These results suggest that the fluorescent puncta
observed in sensory neurons are ApCPEB multimers that result
from direct protein-protein interaction.
Onedistinctive feature of prions is that the ability tomultimerize
and the capacity to self-perpetuate are mediated by different
regions of the protein (Osherovich et al., 2004; Parham et al.,
2001). To test whether Aplysia CPEB multimers have similar
properties we expressed ApCPEB lacking the N-terminal 252
amino acids, which is necessary for efficient multimerization, as
a split fluorescent protein together with the full-length protein.
We found that fluorescence was reconstituted, suggesting that
1–252 amino acids is necessary for multimerization but is not
essential for recruitment to a pre-existing multimer (Figure 3C).
Given that the major unstructured region of ApCPEB extends to
amino acid 350, we also examined a second truncated construct
lacking the first 346 amino acids (Figure S3D). Again we found
thatwhenexpressedwith the full-lengthprotein, the fluorescence
was reconstituted (Figure 3D). Together these results suggest
that the N-terminal unstructured region of Aplysia CPEB is
required for efficient multimerization in the absence of preformed
multimers, but the region following the unstructured region is
sufficient for recruitment to pre-existing multimers.
Aplysia CPEB Multimers Are Amyloids
Themultimerization of ApCPEB in sensory neurons is suggestive
but does not prove that it is prion like. To explore the properties
of ApCPEB multimers further we examined whether the multi-
mers are amyloidogenic. Although all amyloids are not prions,
all prions so far tested form amyloids (Lindquist et al., 1998;
Maddelein et al., 2002; Prusiner et al., 1983; Taylor et al.,
1999). To determine whether ApCPEB can form amyloids, we
performed an in vitro thioflavin T (ThT) binding assay (LeVine,
1999) and also analyzed the multimers under an electron micro-
scope (EM) for the presence of amyloid fibrils (Figures 4A–4D)
(Glover et al., 1997). Thioflavin T binds to b sheets in amyloid olig-
omers to produce a characteristic emission at 482 nm (LeVine,
1999). To initiate multimerization in vitro we allowed purified
recombinant denatured ApCPEB protein to refold (described in
Experimental Procedures) and tested an aliquot for ThT binding
at different time points (Figures 4B and 4C and Figure S4A). We
observed increased ThT fluorescence over time, characteristic
of amyloids (Figure 4C). The ThT fluorescence started to declineCell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc. 425
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Figure 4. ApCPEB Multimers Have Characteristic Features of an Amyloid
(A) The purified recombinant Aplysia CPEB protein (100 ng) used in thioflavin T binding assay and in EM analysis.
(B) Schematic of the experimental design used to obtain oligomeric ApCPEB protein from the recombinant denatured protein. The recombinant ApCPEB was
purified under denaturing conditions and allowed to form fibers by the removal of the denaturant by dialysis.
(C) The emission at 482 nm in arbitrary units after incubation of ThT with ApCPEB. For each time point the ThT fluorescence in buffer is subtracted. Data are
represented as mean ± SEM.
(D) Electron micrograph of recombinant ApCPEB shows fibers similar to known amyloids. When sampled immediately after removal of the denaturant (0 hr) there
is almost no fiber, but after 1 hr the fibers are clearly visible. Scale bar, 200 nm.
(E) The antibody 464 reacts primarily to the oligomeric forms of ApCPEB, whereas antibody 533 and antibody 463 do not show any preference.
(F) Cells expressing HA-tagged ApCPEB were first immunostained for HA expression (red) and then stained with thioflavin S (green). Scale bar, 20 mm.
See also Figure S4.after 4 hr, most likely due to formation of large fibers that do not
bind efficiently to ThT (Figure S4B). Finally, the increase in ThT
fluorescence coincided with the appearance of ordered struc-
tures under EM (Figure 4D and Figure S4B).426 Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc.The immunoprecipitation of endogenous ApCPEB and the
immunostaining of overexpressed ApCPEB suggested that
Ab464 preferentially recognizes themultimeric state of ApCPEB.
To further verify this possibility we probed our multimerization
reaction with Ab464 and observed that in the beginning when
most of the purified ApCPEB protein is either in a denatured or
monomeric state Ab464 shows very little immunoreactivity
(Figure 4E). But within 15 min, as the oligomers begin to show,
Ab464 shows strong reactivity that peaks at 30 min with a kinetic
very similar to that evident with amyloid formation. By contrast
two other Aplysia CPEB antibodies, Ab463 and Ab533, recog-
nized the recombinant protein in denatured, monomeric, and
oligomeric form (Figure 4E). The reactivity of all three antibodies
drops at later time points, which is again very similar to the
amyloid assay, suggesting that large aggregates are mostly mis-
folded amorphous protein aggregates (Figure 4E and Figure S4).
Taken together these results suggest that Ab464 indeed prefer-
entially recognizes a multimeric form of ApCPEB and that the
endogenous multimer and the exogenous multimers might
have conformational similarity.
Finally, to determine whether the exogenous ApCPEB puncta
in sensory neurons are amyloid in nature, we stained these
puncta with thioflavin S (Kimura et al., 2003; LeVine, 1999)
(Figure 4F). The ApCPEBHA in the sensory neurons stained
with thioflavin S (5 mM) produced a punctate green fluorescence
that colocalized with ApCPEBHA staining (red) (Figure 4F). The
punctate green fluorescence is due to selective staining of the
ApCPEBHA multimers. Sensory neurons that did not express
ApCPEB and treated with thioflavin S showed a diffuse green
fluorescence (Figures S4C and S4D).
Taken together these results suggest that ApCPEB can form
amyloids. However, we failed to notice any punctate thioflavin
S staining corresponding to the endogenous ApCPEBmultimers
either in unstimulated or stimulated sensory neurons, presum-
ably due to the smaller size and the small number of endogenous
multimers.
Aplysia CPEB Multimers Are Self-Sustaining
Prion multimers are self-sustaining in nature. One feature of a
self-sustaining multimer, in a nondividing cell, is the capacity to
recruit monomeric proteins to the preformed multimer. To test
whether Aplysia CPEB multimers in neurons are self-sustaining,
we used the photoactivatable green fluorescent protein KiKGR,
which can be irreversibly converted to a red fluorescent protein
by a brief excitation with 405 nm light (Tsutsui et al., 2005). We
expressed ApCPEB-KiKGR fusion protein in the sensory cell
and then converted the existing ApCPEB puncta from green to
red by giving the cell a brief 30 s exposure to 405 nm light. We
now asked, can this (red) pre-existing puncta recruit the newly
synthesized green ApCPEB monomers (Figure 5A)? We
observed that 30min post-conversion, themajority of the puncta
contains red proteins and a low amount of green protein (Figures
5A–5C). However, after 4 hr we began to see green protein
appearing in the red multimers (Figures 5B and 5C), and the
proportion of the green protein in the red multimers increased
over the next 44 hr (Figure 5C and Table S2). It is likely that in
addition to the newly synthesized green protein there is a small
pool of unconverted protein that also became part of the red
puncta. Nevertheless, increase in both the proportion and inten-
sity of green fluorescence over time suggests that the majority of
green fluorescent proteins are newly synthesized (Figure 5C and
Table S2).These observations suggest that the ApCPEB multimers can
continuously recruit new proteins, consistent with the idea of a
self-sustaining multimer. Intriguingly, although new proteins are
recruited, the size of the multimers does not change significantly
over time, suggesting that there is a steady-state size to the
ApCPEB multimers in unstimulated cells (size in mm2; before
ultraviolet [UV], 0.544 ± 0.51; after UV, 4 hr, 0.524 ± 0.38,
24 hr, 0.644 ± 0.43, 48 hr, 0.57 ± 0.35). Finally, most of the
preformed multimers did not change their position over 24 hr
suggesting that once formed the multimers are relatively immo-
bile (Figure 5D). Thus it is unlikely that preformed multimers from
the cell body moved to the neurite regions, and the multimers we
observed in the neurites most likely are formed locally.
Multimerization of Aplysia CPEB Is Regulated by 5-HT
All known examples of prion-like conversions are stochastic in
nature. However, our model postulates that the conversion of
ApCPEB to the multimeric state should be regulated by synaptic
activity. To address this question we expressed ApCPEBEGFP
in the sensory-motor neuron coculture, waited 48 hr for the
expression to reach a steady-state level, and then stimulated
the cells with 5 pulses of 5-HT, the modulatory transmitter
released during learning (Figure 6A). In the stimulated cells we
observed an increase in the number of detectable puncta
compared to the unstimulated cells (% change in number of
puncta/neurite; mock-treated, 1.2 ± 3.3, n = 10, 535-HT treated,
15.7 ± 2.7, n = 13; t test, p < 0.005) (Figures 6B and 6C).
The increase in puncta formation of ApCPEB could be due to
(1) enhanced transcription and translation, (2) stabilization, or (3)
enhanced conversion to the multimeric state. In an attempt to
distinguish between these possibilities, we used the Drosophila
homolog of ApCPEB, Orb2, which displays a species barrier
(our unpublished data). We reasoned that if we expressed
Orb2 in Aplysia sensory neurons, an increase in endogenous
ApCPEB following 5-HT treatment should have no effect on
the Orb2 protein and should not influence its conversion
(Figure 6D). However, if synaptic stimulation engages a specific
signaling pathway that promotes conversion to the multimeric
state, it might be shared with Orb2 and as a result influence its
multimerization. Orb2 has two isoforms, Orb2RA and Orb2RB,
and Orb2RA is similar to ApCPEB in its domain organization
(our unpublished data). We therefore expressed Orb2RAEGFP
in the sensory neuron of a sensory-motor neuron coculture and
observed that unlike ApCPEB, Orb2RA formed very few detect-
able puncta (>3 pixels) in the unstimulated Aplysia sensory
neuron. This suggests that most of the Orb2RA protein in unsti-
mulated sensory neurons is either monomeric or exists as small
multimers (Figures 6D and 6E). However, upon stimulation of the
same neurons by bath application of 5 pulses of 5-HT, Orb2RA
formed significantly more puncta (>3 pixels) throughout the
neurites (Figures 6D and 6E, number of puncta/neurite; before
5-HT treatment, 1 ± 0.52, n = 7; after 535-HT treatment, 26.8 ±
5.2, n = 7; t test, p < 0.005).
The conversion to the punctate state was independent of the
tag as Orb2RA tagged with HA showed a similar increase in
the number of detectable puncta following 5-HT (Figures S5A,
S5B, and S5G; number of puncta/neurite; unstimulated cells,
4.6 ± 1.4, n = 9; 535-HT treated cells, 38.5 ± 9.5, n = 8; t test,Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc. 427
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Figure 5. ApCPEB Multimers Are Self-Sustaining
(A) Representative example of a cell before and after photoconversion imaged at the indicated times using Ar (488 nm) for unconverted or He/Ne (543 nm) lasers
for photoconverted form of KiKGR. Left panel: imaged for the green fluorescence. Middle panel: imaged for the red fluorescence. Right panel: merged image.
The recruitment of newly synthesized green protein to the pre-existing red multimeric structure is clearly visible over time. In the merged image they appear as
yellow. The images are projections of stacked images. The box indicates the area scanned for the histogram in (B).
(B) Fluorescence intensity plot of single 1 mm confocal section shows photoconversion and subsequent recruitment of newly synthesized green protein.
The intensity is in arbitary units.
(C) Plot of average pixel intensity of green and red fluorescence in a punctae and the ratio of green fluorescence to red fluorescence over time. The number of
punctae analyzed for each time point are 110 (before UV), 89 (30 min after), 96 (4 hr after), 92 (24 hr after), and 84 (48 hr after).
(D) Higher-magnification images of the 24 hr and 48 hr time points show that the position of most of the puncta does not change over a 24 hr period.
Scale bar, 20 mm. See also Table S2.p < 0.005). In contrast, when we expressed the Orb2RB isoform,
in which the prion-like domain is located inside the protein,
neither untreated nor treated cells showed any puncta that are
>3 pixels (Figures S5C and S5D). In these experiments, the
Orb2RA open reading frame was expressed under a viral
promoter and thus it was unlikely that the transcription or the
translation of Orb2RA was affected by the 5-HT stimulation. The
enhanced conversion could be due to protein stabilization and
the concomitant increase in effective concentration or through
the recruitment of accessory proteins or posttranslational modi-
fication that facilitates conversion. Since we could not determine
the amount of CPEB protein from a single injected cell we could
not distinguish between these possibilities. Nonetheless, these
results suggest that multimerization of exogenous neuronal
CPEB can be regulated by 5-HT.
Is multimerization of the endogenous ApCPEB regulated by
5-HT? When we immunostained the 5-HT-stimulated sensory428 Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc.neuron with Ab464, we did not observe any detectable staining.
To detect small amounts of multimer in a quantifiable manner
we used a membrane-trap assay that has previously been used
to detect SDS-insoluble polyQ and Huntington oligomers as
well as the oligomer-specific epitopes of Ab, Huntington, and a-
synuclein proteins (Kayed et al., 2003; Muchowski et al., 2002;
Scherzinger et al., 1997; Wacker et al., 2004). In this assay, total
protein extracts were prepared from the CNS in a buffer contain-
ing 20mMEDTA, 50mMDTT, and 2%SDS to disruptmost RNA-
protein and protein-protein interactions, and we then passed the
extract through a nitrocellulose membrane (0.2 mm pore size) to
trap protein oligomers (Figure 6F). To further ensure that we are
scoring self-assembled oligomers of ApCPEB rather than protein
complexes, one set of samples was boiled for 5 min prior to
passing it through the membrane. We observed that 8 hr after
stimulation with 5-HT, the immunoreactivity of the proteins that
were retained in the membrane to Ab464 increased almost
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Figure 6. ApCPEB Multimerization Can Be Induced by 5-HT
(A) Schematic of the experimental design. Sensory neurons in the sensory-motor neuron coculture were injected with the indicated DNA and incubated for 2 days
for expression to reach a steady-state level. Expressing cells were stimulated with 5 pulses of 5-HT, a protocol known to produce long-term facilitation of the
sensory-motor neuron synapse and imaged at the indicated times.
(B) Representative image of unstimulated and stimulated cells expressing ApCPEBEGFP.
(C) Quantification of the 535-HT dependent increase in ApCPEBEGFP puncta indicated as percent change in the number of multimers. For quantification
unstimulated cells were compared 24 hr after stimulation with 535-HT.
(D) Representative images of Aplysia sensory neurons expressing EGFP-tagged Drosophila Orb2RA before and after stimulation with 5-HT.
(E) Quantification of the 535-HT dependent increase in Orb2RAmultimerization given as average number of multimers rather than percent change due to the low
starting number. Scale bar, 20 mm. Data are represented as mean ± SEM.
(F) Stimulation with serotonin enhances the reactivity to ApCPEB multimer-specific antibody 464. The high molecular weight protein complexes in the Aplysia
CNS were trapped into nitrocellulose membrane and blotted with Ab464. Samples were kept at room temperature (25C) or boiled for 5 min (100C) before
applying to the nitrocellulose membrane. The Ab464 reacting component is stable after boiling for 5 min. The Ab463 recognizes both forms of the protein.
The low reactivity to Ab463 suggests that most of the monomeric ApCPEB was not retained in the membrane. The ponceauS staining shows that similar amount
of total proteins was retained for each time point.
(G) Quantification of the fold induction of Ab464 reactivity following stimulation with 5-HT. The box andwhisker plot represents standard deviation and distribution
in independent experiments, respectively. The horizontal lines indicate mean fold induction. Data are represented in the text as mean ± SEM.
See also Figure S5.5-fold compared to the unstimulated sample (fold increase,
mean ± SEM; nonboiled: 5.11 ± 0.67, boiled: 5.963 ± 1.08; n = 7,
t test, p < 0.005) (Figures 6F and 6G). Interestingly, no such
increase in Ab464 reactivity was observed 4 hr after stimulation
(mean fold increase; nonboiled: 1.31 ± 0.20, boiled: 0.94 ± 0.49;
n = 3, t test, p > 0.05), although the amount of total protein re-
tained in the membrane was similar to 8 hr (Figures 6F and 6G).
This suggests that there is a time lag between induction of the
monomeric ApCPEB, which occurs within 1 hr after stimulation
(Si et al., 2003a), and the accumulation of the multimeric form.Taken together, we conclude from these results that serotonin
enhances multimerization of ApCPEB in the nervous system.
However, we do not know whether it is due to an increase in
protein concentration or enhanced conversion of the pre-exist-
ing proteins. These results also suggest that the endogenous
protein most likely exists in the multimeric state only at a subset
of active synapses and thus is relatively rare compared to the
monomeric form. Consistent with this idea, when we analyzed
the total protein extract from the central nervous system in a
low-salt sucrose gradient, the detectable ApCPEB migrated asCell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc. 429
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Figure 7. ApCPEB Multimers Are Active and Required for the Persistence of Long-Term Facilitation
(A) Schematic of the experimental design. In (B)–(D), EGFP-tagged DNA of the indicated constructs was injected in the sensory neuron (SN). Twenty-four hours
after injection, cells were stimulated with bath application of 5-HT. In (E) antibodies were injected and 2 hr after injection, cells were stimulated with bath appli-
cation of 5-HT. (B) Ectopic ApCPEB multimers inhibit persistence of 5-HT-mediated long-term facilitation (LTF) of Aplysia sensory-motor synapse beyond 24 hr.
The ApCPEB lacking RNA-binding ability (C) or lacking the prion-like domain (D) did not have any effect on the persistent phase of LTF. (E) The multimeric form of
endogenous ApCPEB is required for the persistence of LTF. Injection of Ab464, but not of control IgG, to the sensory neuron of sensory-motor neuron culture
selectively blocked the persistence of LTF of sensory-motor neuron synapse beyond 24 hr. Data are represented as mean ± SEM. See also Figure S6.a low molecular weight protein similar in size to the monomeric
form of the protein (Figure S5H).
Extrasynaptic Aplysia CPEB Multimers Interfere
Selectively with the Maintenance of Long-Term
Facilitation
The data we have presented so far indicate that ApCPEB has
some of the properties of a prion-like protein in neurons. This
in turn raises the question, what is the functional consequence
of attaining the prion-like multimeric state in neurons? When
we overexpressed ApCPEB in the sensory neuron, multimers
formed all over the neurite and a number of them formed outside
the synaptic area (Figure S6). These ApCPEB multimers that
formed outside the synaptic region do not interfere with basal
synaptic function (control: % change in excitatory postsynaptic
potential [EPSP] after 24 hr: 1.1% ± 5.6%, after 48 hr: 6.45% ±
13.31%, n = 7, t test, p > 0.5; cells expressing ApCPEB: %
change in EPSP after 24 hr: 1.2% ± 2.8%, after 48 hr:
1.92% ± 4.17%, n = 7, t test, p > 0.5). We next explored the
effect of these multimers in synaptic facilitation (Figure 7A). We430 Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc.induced long-term synaptic facilitation in the sensory-motor
neuron synapses by bath application of 5 pulses of 5-HT (10 mM).
This protocol induced long-term facilitation in the cells injected
with the plasmid alone at 24 hr (% increase in mean EPSP at
24 hr: 89.8% ± 19.9%, n = 13) and the facilitation persisted
beyond 48 hr (% increase in mean EPSP at 48 hr: 72.3% ±
17.4%, n = 13) (Figure 7B). The cells expressing ApCPEB multi-
mers also showed an increase in EPSPs at 24 hr (% increase in
mean EPSP at 24 hr: 67.8 ± 13.7, n = 9). However, unlike the
control cells the facilitation did not persist for 48 hr (% increase
in mean EPSP at 48 hr: 11.3 ± 14.1, n = 9) (Figure 7B). This
phenotype is similar to what we have previously observed
when we blocked the ApCPEB activity in the neurites using
antisense oligonucleotides to CPEB (Miniaci et al., 2008;
Si et al., 2003a).
The selective inhibition of long-term synaptic facilitation upon
overexpression of ApCPEB could be a nonspecific effect of the
presence of large number of multimers in the cell. Alternatively
ApCPEB multimers in sensory neurons could be active and
might bind to target mRNAs as we have previously observed
in vitro (Si et al., 2003b). Upon overexpression these activemulti-
mers, formed outside the synaptic area, can bind to and
sequester the target mRNAs and prevent them from reaching
the synapse. This could result in a dampening of ApCPEB target
mRNA translation in the activated synapse.
To distinguish between these possibilities we first expressed
ApCPEBrbm that is efficient in multimer formation but has
reduced capacity to bind mRNA (Figure 7C). Unlike cells ex-
pressing wild-type ApCPEB, in cells expressing ApCPEBrbm,
long-term facilitation induced by 5-HT now persisted for 48 hr
after exposure to 5-HT similar to control cells (% increase in
mean EPSP at 24 hr; control: 81.8% ± 8.8%versus ApCPEBrbm:
90.3% ± 26.7%, n = 7; at 48 hr; control: 64.9% ± 8.3% versus
ApCPEBrbm: 61.9 ± 19.3%, n = 7) (Figure 7C). Thus the ability
of the extrasynaptic multimers to bind mRNA is critical for the
inhibition. The presence of the multimers alone is not sufficient
to inhibit the persistence of the facilitation. We next expressed
N-terminally truncated ApCPEB, ApCPEBDN, that contains the
domains necessary for binding to mRNA but that is inefficient
in multimer formation (Figure 1E). Again, in contrast to the
full-length ApCPEB, cells expressing ApCPEBDN showed
long-term facilitation that persisted at both 24 hr after 5-HT treat-
ment (% increase in mean EPSP at 24 hr; control: 81.8% ± 8.8%
versus ApCPEBDN: 96.5% ± 31.7%, n = 8) and at 48 hr
(% increase in mean EPSP at 48 hr; control: 64.9% ± 8.3%
versus ApCPEBDN: 65.3% ± 22.4%, n = 8) (Figure 7D). Taken
together, these results suggest that the ectopic ApCPEBEGFP
multimers are active in binding to target mRNA and thereby
inhibit persistence of long-term facilitation.
An Antibody that Preferentially Recognizes
the Multimeric ApCPEB Blocks Persistence
of Synaptic Facilitation
If ApCPEB indeed acts as an active multimer, then one would
predict that inhibition of the endogenousmultimeric form of ApC-
PEB should destabilize themaintenance of long-term facilitation.
To test this prediction we took advantage of the antibody 464
(Ab464) that preferentially binds the multimeric form of Aplysia
CPEB (Figures 1H and 4E) and injected this antibody into the
sensory cell of sensory-motor neuron culture (Figure 7E). We
assumed that binding of antibody to the protein would either
inhibit or diminish its activity. Injection of the Ab464 interferes
neither with basal synaptic transmission (% change in EPSP:
after 24 hr; uninjected, 11% ± 14.1%; control IgG, 11% ±
13.2%; Ab464, 3.37% ± 6.53%, and after 48 hr; uninjected,
2.37% ± 13.2%; control IgG, 9% ± 8.49%; Ab464, 9% ±
8.14%, n = 8) nor with long-term facilitation measured at 24 hr
post-bath application of 5 pulses of 5-HT (% change in EPSP;
24 hr after 5-HT stimulation; uninjected, n = 13, 102.46% ±
14.5%; control IgG, n = 12, 103.33% ± 14.5%; Ab464, n = 12,
104.17% ± 20.6%, p > 0.05, two-way ANOVA) (Figure 7E).
However, unlike the control cells, synaptic facilitation failed to
persist up to 48 hr in Ab464-injected cells (% change in EPSP
48 hr after 5-HT stimulation: uninjected, n = 13, 64.23% ± 11%;
control IgG, n = 12, 72.18% ± 20.1%; Ab464, n = 12, 11.17% ±
8.69%, p < 0.01, two-way ANOVA). These results indicate that
the multimeric form of Aplysia CPEB is involved in long-term
stabilization of activity-dependent change in synaptic efficacy.DISCUSSION
Exogenous Aplysia CPEB in Sensory Neurons Exhibits
Some of the Canonical Properties of a Prion-like Protein
Our earlier studies in yeast suggested that ApCPEB can behave
like a prion and retains its biochemical activity in the prion-like
state. As this is the first example of a higher eukaryotic protein
that has prion-like properties yet still has the potential for phys-
iological function, it raised the question as to whether ApCPEB
behaves like a prion in the proper cellular context of the nervous
system.
We therefore explored the properties of ApCPEB in Aplysia
sensory neurons and found that it has properties that are consis-
tent with it being a self-sustaining prion-like protein. First, as in
yeast, in Aplysia sensory neurons, ApCPEB also exists in two
states: a monomeric and a multimeric state. Second, the protein
achieves its multimeric state through self-assembly. Third, the
multimeric state of the protein has the capacity to recruit new
protein and therefore is self-sustaining. Finally, the multimeric
state of the protein shares properties of amyloids. These proper-
ties are similar to those observed in other prions, but direct
evidence for a distinct conformational change between the
monomeric and a multimeric state has proven difficult to obtain.
In our experiments, prion-like properties are tested with the
overexpression of ApCPEB protein; thus, the question of
whether the endogenous and exogenous multimers are similar
in nature is raised. The finding that Ab464 antibody recognizes
both the endogenous high molecular weight ApCPEB as well
as the ApCPEB puncta formed upon overexpression suggests
that endogenous multimeric ApCPEB is conformationally similar
to the puncta formed by the exogenous protein. However, the
size of the endogenous multimer is smaller compared to the
size we observe when we overexpressed ApCPEB in sensory
neurons. We have observed a similar smaller multimer with
Drosophila CPEB, Orb2 (our unpublished data). One possibility
is that the smaller endogenous multimer results from the disso-
ciation of the larger multimer following boiling in SDS buffer.
The other possibility is that in cellular concentrations the prion-
like state is a small oligomer, which grows into larger structures
when overexpressed. Consistent with a smaller multimeric state
we observed only diffuse staining of ApCPEB in the neurites
when we immunostained either stimulated or unstimulated
sensory neurons (Si et al., 2003a). However we cannot rule out
the possibility that some of the prion-like properties that we
have observed in sensory neuron are a result of overexpression
of ApCPEB.
Aplysia CPEB Has Properties Distinct
from Known Prions
There are several features of the prion-like state of ApCPEB that
are distinctly different from the pathological PrP protein or non-
pathological but inactive state of yeast prions. First, Although
ApCPEB forms a large number of multimers in Aplysia sensory
neurons, these multimers had no adverse effect either on basal
synaptic functions or on survival of the neurons over days.
Second, although indirect, our results suggest that unlike other
known prions that are inactive, ApCPEB retains biochemical
activity in its multimeric state such as the ability to bind mRNA.Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc. 431
However it is not yet evident whether these are active sites of
poly(A) tail elongation or protein synthesis. Third, in all known
prions the conversion to the prion state is spontaneous. In
contrast, conversion of ApCPEB to the multimeric state is regu-
lated by a physiological signal, repeated pulses of 5-HT. Finally,
antibodies that recognize the multimeric form of ApCPEB selec-
tively interfere with the persistence of synaptic facilitation
beyond 24 hr.
What would be the advantage of having a prion-like multime-
rization? In addition to self-sustenance, a simple possibility is
that multimerization of the ApCPEB leads to a net increase in
activity by increasing the number of active units. If the mono-
meric form of the protein has weak activity, having multiple units
would effectively increase activity. In addition there might be
other, more interesting possibilities. The prion-like multimeriza-
tion requires a significant conformational conversion, which in
addition to preserving the original activity might confer new
activities to the protein.
Are Neuronal CPEBs a New Class of Functional
Prion-like Proteins?
All proteins that multimerize in the cell are clearly not prions.
There also are many instances when multimerization of a protein
can be changed in response to external signals such as polymer-
ization of actin (Higgs and Pollard, 2001). ApCPEB forms self-
sustaining multimers with the properties of an amyloid. But are
these features sufficient to categorize ApCPEB as a prion-like
protein?
The term prion has taken on two meanings. The first derives
from the unique disease causing properties of the PrP protein
PrPsc. One of the most remarkable aspects of the prion disease
is the ability of the PrPsc protein to be absorbed in the digestive
system to enter the circulation, cross the blood brain barrier, and
enter the central nervous system where the protein propagates
the disease. By this definition of infectivity, only PrPsc and no
other protein, including yeast or fungal prions, can be catego-
rized as prions (Weissmann, 2004). The second definition of
prion is mechanistic and is based on the ability of the disease-
causing state of the protein to induce its own conformational
state onto the non-disease-causing form of the protein, resulting
in self-propagation. This second feature of the prion disease is
more general (Meyer-Luehmann et al., 2006) and is manifested
by a number of yeast proteins and at least one fungal protein
(Coustou et al., 1997; Derkatch et al., 2001; Osherovich and
Weissman, 2001; Sondheimer and Lindquist, 2000; Wickner
et al., 1995). We have now found that the self-propagation is
manifested by Aplysia neuronal CPEB. It is possible that the
ability of a prion-like protein to assume a self-propagating
conformational state is part of an evolutionarily conserved
molecular mechanism that can create two distinct activity states
from a single polypeptide (Osherovich and Weissman, 2002;
Shorter and Lindquist, 2005). In the case of the prion disease,
the PrP protein has acquired additional features that result in
its remarkable infectivity. We would suggest that the Aplysia
CPEB might be representative of a new class of proteins that
utilize a self-perpetuating multimeric state to create self-
sustaining altered activity state in the cell in response to specific
stimuli.432 Cell 140, 421–435, February 5, 2010 ª2010 Elsevier Inc.EXPERIMENTAL PROCEDURES
Plasmids
All constructs for injection into the Aplysia sensory neurons were made in the
Aplysia expression vector pNEX3 (Kaang, 1996). The circularly permutated
EGFP protein was fused to the C-terminal end of ApCPEB by creating in-frame
SpeI restriction enzyme sites in the N-terminal end of EGFP and C-terminal
end of ApCPEB by PCR. To make ApCPEBEGFP, a BamHI/blunt-ended
ApCPEBEGFP fragment was cloned into the BamHI/SmaI sites of pNEX3.
To make mouseCPEB1EGFP, yeast Sup35 NMEGFP, ApPrdEGFP, and
72QEGFP a BamHI site was introduced into the N-terminal end and a SpeI
site was introduced into the C-terminal end of mouse CPEB1, NM, ApPrd,
and 72Q. A plasmid bearing 72Q amino acids was obtained from the lab of
Dr. Susan Lindquist (MIT). To make the pNEX3 constructs, first ApCPEB
was removed from the pNEX3ApCPEBEGFP with BamHI/Spe1 and replaced
with BamHI/SpeI digested mouseCPEB1, NM, ApPrd, and 72Q. To create
ApPrdMouseCPEB1 and 72Q mouseCPEB1, in-frame XhoI sites were intro-
duced into the C-terminal end of ApPrd, 72Q, and N-terminal end of mouse
CPEB1. To clone into the pNEX3 vector ApPrd and 72Q were digested
with BamHI/XhoI, Mouse CPEB1 was digested with XhoI/SpeI, and the two
fragments were ligated with pNEX3EGFP BamHI/SpeI cut vector. To make
ApPrdStaufenEGFP construct, an in-frame XhoI site was introduced into the
N-terminal end of the Aplysia Staufen and a SpeI site was introduced into
the C-terminal end of the fragment. The BamHI/XhoI digested ApPrd and
XhoI/SpeI digested Aplysia Staufen were ligated with BamHI/SpeI digested
pNEX3EGFP. To make ApCPEBEGFPrbm, Cys664 and His672 residues in
the zinc finger domain were mutated to alanine residues by using the primer
pairs 50CAAGTACCTTGCTCGCTCCTGCTGGTACTGGCAGGCCGCCCCGG
AC30 and 50GTCCGGGGCGGCCTGCCAGTACCAGCAGGAGCGAGCAAGGT
ACT TG30. The ApPrdMouseCPEB1rbm was created by mutating the Cys526
and His544 to alanine residues using two sets of primer pairs. The first set of
primer pairs were 50GGTCCTTTCTTCGCCCGAGATCAGGTC30 and 50 GACC
TGATCTCGGGCGA-AGAAAGGACC30, and the second set of primer pairs
were 50TGGCAC TGGCGAGCCAGCATGGAAGGC30 and 50GCCTTCCATGC
TGGCTCGCCAGTG CCA30. To make ApCPEB lacking the N-terminal 252
amino acids or 346 amino acids, BamHI sites were created after the indicated
residue at theN-terminal end. Tomake ApCPEBHA, HApeptide sequencewas
introduced into the C-terminal end using the primer 50TCCCCCGGGTTACTA
AGCGTAGTCTGGGACGTCGTATGGGTAGAG AGACAGAGATGACTTGGT30.
Cell Culture and Injection
Aplysia sensory-motor neuron cultures and electrophysiology were done as
described in Montarolo et al. (1986). For injection the close circular plasmid
DNAs were purified from 500 ml of bacterial culture using Cesium Chloride
purification (Molecular biology Hand book) and injected using the protocol
as described in Kaang et al. (1992). Antibody solutions of 100 mg/ml concen-
tration were used for injection. For all experiments, 4- to 5-day-old cultures
were used.
Antibodies
To raise antibodies against Aplysia CPEB N-terminal domain, the N-terminal
213 amino acids were expressed as N-terminal 6-Histidine-tagged protein in
E. coli and purified under denaturing condition (QIAGEN). For antibody 463
and 533 the purified recombinant protein was run in an SDS-PAGE and the
gel fragment was injected in rabbit (Covance). For antibody 464 the purified
recombinant protein was dialyzed against 1M urea and the aggregated protein
was injected in rabbit (Covance). The antibody 464 was obtained after several
attempts. The crude serum was purified in an affinity column containing the
purified aggregated recombinant protein and the affinity purified antibody
was used for all experiments. The antibody 77 has been described before
(Si et al., 2003b). The rabbit antibody against Human Dcp1b was kindly
provided by J. Lykke-Andersen of the University of Colorado, Boulder.
Immunoprecipitation and Western Blotting
Pleural and pedal ganglia from 10 animals (size100 g) were isolated and total
protein was extracted using PBS buffer containing 0.1% Triton X-100 (PBST)
and protease inhibitor (GE Healthcare). Approximately 0.5 mg of total protein
was incubated with each antibody overnight at 4C and the antibody-protein
complex was isolated by incubating with proteinA-sepharose (Sigma) beads
for 1 hr at 4C. The beads were washed four times with PBST, boiled for
5 min in SDS-PAGE sample loading buffer, and analyzed on an 8% SDS-
PAGE gel. For western, 1:500 dilution of Ab77 and 1:1000 dilution of Ab463
were used.
For western blotting total protein extracts were prepared from Aplysia
pleural and pedal ganglia in a buffer containing 600 mM KCl, 10 mM HEPES
(pH 7.4), 3 mM MgCl2, 1 mM DTT, and 0.2% NP-40. Approximately 25 mg of
total protein was separated in 10% SDS-PAGE and electroblotted to PVDF
membrane (Amersham).
Filter-Trap Assay
The assay was adopted fromScherzinger et al. (1997) andWacker et al. (2004).
Aplysia californica (80–100 g) were rested for 4 days and treated with 100 mM
serotonin for 1 hr in sea water at 18C (Hegde et al., 1993; Si et al., 2003a).
Following stimulation the animals were moved to fresh sea water and 3 hr or
7 hr post-stimulation the pleural and pedal ganglia were isolated. The total
CNS extract was prepared in a buffer containing 20 mM EDTA, 50 mM DTT,
2%SDS, and protease inhibitors (GE healthcare). The total protein extract
was centrifuged twice, 10 min each, at 12,000 3 g at 4C, and approximately
75 mg of total protein from the clear supernatant was vacuum blotted to a
nitrocellulose membrane (Schleicher & Schuell) using a dot-blot apparatus
(BioRad). The membranes were probed with affinity-purified Ab464 (1:1000)
or Ab463 (1:1000), and the western blots were quantified using Image Quant.
Indirect Immunostaining
Immunostainingswere performed using standard protocols. Briefly, forAplysia
sensory neurons, 2 days post-injection cells were washed with artificial sea
water and fixed with 4% cold paraformaldehyde in 30% sucrose for 10 min
at room temperature. Cells were subsequently washed, blocked in PBS
containing 0.1% Triton X-100 and 10% Goat serum (Life Technologies), and
incubated with primary and secondary antibodies in the blocking buffer. The
primary antibodies were used in the following dilutions: anti-HA 1:500 (GE
Healthcare, 12CA5), affinity-purified Ab 464 1:100, anti-hDcp1b 1:100. The
secondary antibodies were used in the following dilutions: anti-mouse coupled
to Cy3 1:500 (Molecular probes), anti-rabbit coupled to Cy3 1:500 (Molecular
probes), anti-rabbit coupled to Alexa 488 1:500 (Molecular Probes).
Thioflavin T Binding Assay
The 6-histidine-tagged ApCPEB protein was purified under denaturing condi-
tions in Ni+2-Agarose column following manufacturers protocol (QIAGEN).
The purified Aplysia CPEB protein in 6M GnHCl-PBS buffer was dialyzed
against a buffer containing 1M Urea, 100 mM KCl, 10 mM Na-HEPES
(pH 7.6), 1 mM DTT, 0.1 mM CaCl2, 1 mM MgCl2, and 5% Glycerol at room
temperature to initiate fiber formation. The thioflavin T binding assay was per-
formed essentially as described by LeVine (1999). Briefly, 400 picomole of
protein/100 ml aliquots were taken at indicated time and mixed with 700 ml of
25 mM thioflavin T (Sigma) in 50 mM Glycine buffer (pH 8.5). The reaction
mix was excited at 442 nm and the emission spectra at 482 nmweremeasured
using Fluoromax-3 spectrofluorimeter. For each sample three independent
measurements were taken. To obtain the fluorescence due to ApCPEB just
the 6M GnHCl-PBS buffer was similarly dialyzed and for each time point ThT
fluorescence in buffer alone value was subtracted.
EM Analysis
For electron microscopy 2 ml of proteins aliquots were taken at the indicated
time during dialysis against 1M Urea, 100 mM KCl, 10mM Na-HEPES
(pH 7.6), 1mM DTT, 0.1 mM CaCl2, 1mM MgCl2 and 5% Glycerol at room
temperature. The sample was deposited on the 400 mesh carbon-coated
grid (Electron Microscopy Sciences), allowed to settle for approximately one
minute, blotted dry with a piece of filter paper, and then covered with a small
drop of 1% uranyl acetate in water. After a few seconds, this drop was also
blotted dry, and the sample was examined on a FEI Tecnai G2 Spirit at 88kV
accelerating voltage. We obtained digital images using a bottom-mount Gatan
TEM camera.Microscopy and Image Analysis
All images were obtained with a Zeiss LSM 5.0 Pascal confocal microscope.
For Aplysia sensory cells a plan-Neofluar 403/1.3 Oil DIC objective was
used. All images were obtained as stacked images in multi-track scan mode
with 1.0 mm step at 5123512 pixels (pixel depth 8 bit) for Aplysia. For EGFP
the 488 nm laser was used for excitation and the emitted light between
505–530 nm was collected. All images shown are projections of the stacked
images that spanned the entire depth of the neurite. The image conditions
were optimized to prevent photo bleaching, signal contamination, and
saturation. For each experimental set the same imaging conditions and
parameters were used. For all comparative analysis, cells injected in the
same day were used for both the experimental and control group. Cells
were always kept at 18C except when the cells were imaged, which was
done at room temperature.
For image analysis only the neurite region of each cell was used to avoid the
autofluorescence of the cell body region. As it is difficult to distinguish indi-
vidual puncta in the neurite region close to the cell body, in all cases we
measured the punctate structures 20 mm away from the cell body, and
because we could not unequivocally delineate the area of the neurite from
DIC images we counted all puncta that are above background. Because
some punctate structures spanned over more than one section, for quantifica-
tion of the number of puncta, the Z stacks were projected into a single image
and analyzed using Axiovision software using dynamic threshold. The
threshold for each channel was set to optimize the detection of punctate struc-
tures that are >3 pixels andmaintained throughout the analysis for each exper-
imental set. In each experiment an uninjected cell was imaged under identical
conditions for measurement of the background fluorescence. The following
measurements were acquired by an automatic program: number of regions,
area of region, and densitometric mean. These values represent number of
puncta, area covered by puncta, and intensity of puncta, respectively. Statis-
tically significant differences were assessed by one-way ANOVA and
Student’s t test.
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